Gene: CRIPT
Official Full Name: CXXC repeat containing interactor of PDZ3 domainprovided by HGNC
Gene Summary: This gene encodes a protein that binds to the PDZ3 peptide recognition domain. The encoded protein may modulates protein interactions with the cytoskeleton. A mutation in this gene resulted in short stature with microcephaly and distinctive facies. [provided by RefSeq, Jun 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06206 | CRIPT Knockout cell line (HeLa) | Human | CRIPT | 1:3~1:6 | Negative | Online Inquiry |
KO06207 | CRIPT Knockout cell line (HCT 116) | Human | CRIPT | 1:2~1:4 | Negative | Online Inquiry |
KO06208 | CRIPT Knockout cell line (HEK293) | Human | CRIPT | 1:3~1:6 | Negative | Online Inquiry |
KO06209 | CRIPT Knockout cell line (A549) | Human | CRIPT | 1:3~1:4 | Negative | Online Inquiry |
CRIPT Gene Knockout Cell Lines are engineered cellular models that have been specifically developed to silence or eliminate the expression of the CRIPT gene, a critical component in various cellular processes, including proliferation and signal transduction pathways. By utilizing cutting-edge CRISPR-Cas9 technology, these cell lines allow researchers to investigate the specific functions of the CRIPT gene in both physiological and pathological contexts.
The primary function of CRIPT Gene Knockout Cell Lines lies in their ability to provide a controlled environment in which the effects of CRIPT gene disruption can be rigorously studied. This is crucial for understanding CRIPT's role in cellular signaling and its implications in disease states, such as cancers and developmental disorders. The knockout mechanism ensures that the CRIPT gene is wholly inactive, allowing researchers to observe subsequent changes in the cellular behavior, gene expression profiles, and metabolic functions, thus shedding light on its biological significance.
Scientifically, these cell lines hold immense value in academic and clinical research settings, providing a reliable platform for screening potential therapeutic agents, identifying novel biomarkers, and elucidating gene functions. The ability to study the CRIPT gene in isolation can lead to breakthroughs in gene therapy approaches and precision medicine, making them invaluable in exploring innovative treatments for genetic disorders.
One of the standout advantages of our CRIPT Gene Knockout Cell Lines over alternative models is the precision and efficacy of gene editing through our optimized protocols. Additionally, our cell lines are thoroughly validated for specific expression profiles and cellular behaviors, providing researchers with high-quality, reproducible models. Users will appreciate the significant reduction in experimental variability and increased confidence in their results.
The value of CRIPT Gene Knockout Cell Lines to researchers and clinicians extends beyond mere experimentation; they are essential tools that facilitate the discovery of new therapeutic pathways and enhance our understanding of complex biological systems. Our commitment to quality and innovation in cell line development demonstrates our expertise in providing advanced biological products tailored to meet the evolving needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.